Organon & Co.

Organon & Co.

OGN - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$3.63B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Organon & Co.Organon & Co.17.50.58%10448%0.88.6
$15.49

Current Fair Value

12% upside

Undervalued by 12% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$3.63 Billion
Enterprise Value$3.64 Billion
Annual dividend$0.08
Dividend yield0.58%
Earnings per Share$0.72
Beta1.54
Outstanding Shares262,616,000

Return

Return on Equity10448.11%ROE
Return on Assets797.60%
Return on Invested Capital8164.39%

Valuation & Multiples

P/E Ratio17.52P/E Ratio
PEG700.76PEG
Price to Sales0.81Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue0.8
Enterprise Value to EBIT4.22
Enterprise Value to Net Income34
Total Debt to Enterprise0
Debt to Equity8.59Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
October 30, 2026
EPS Estimate
$0.88
Consensus analyst estimate
Revenue Estimate
$1.58 B
Consensus analyst estimate

Next Earnings Call

Expected Date
November 9, 2026
EPS Estimate
$0.88
Consensus analyst estimate
Revenue Estimate
$1.58 B
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.0000▼ 103.99%
Total Calls20▼ 100.00%
Total Puts-▼ 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %1.01%▼ 84.28%
Total Invested$36.16M▼ 98.79%
Investors Holding189▼ 473.00%

About Organon & Co.

Organon Insider Information FAQ

Stockcircle tracks 8 top investors with a current 13F position in Organon. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 2 top investors increased or opened positions and 7 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle shows 1 open-market insider purchase and 2 open-market insider sales for Organon in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Stockcircle lists 2 politician trade disclosures tied to Organon in the last twelve months, drawn from periodic financial disclosure reports. 1 politician traded Organon in the past year.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.